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   eukoplakias are oral lesions that may have many clinical and histological aspects and they are usually associated with
malignancy when dysplastic alterations are shown. However, these transformations may occur in non-dysplastic lesions that
show harmless clinical aspect. For this reason, the proposal was to study the p53 and PCNA immunohistochemical expression
in non-dysplastic leukoplakias, trying to correlate the results only with the epithelial keratinization degree. For this, 24 leukoplakias
degrees I, II and III of Grinspan were used, all of them located in oral mucosa. Most of the leukoplakias showed p53 and PCNA
expression in their different keratinization degrees. The p53 marking was confined to the basal and parabasal layers, while the
PCNA marking occurred in practically all epithelial layers. The expression pattern of these markers was histologically and
statistically similar between the lesions with these keratinization variations. It was evident that non-dysplastic epithelium of
leukoplakias showed submicroscopical signs of alterations that lead to malignant transformation, and that the keratinization
degree did not correlate to a greater risk of this event.
Uniterms: Leukoplakia;  Immunohistochemistry; p53; Proliferating cell nuclear antigen (PCNA).
   s leucoplasias são lesões orais que podem apresentar vários aspectos clínicos e histológicos e são associadas à malignidade
geralmente quando apresentam alterações displásicas. Contudo, essas transformações podem ocorrer em lesões sem displasia
que apresentam aspecto clínico inocente. Por esse motivo nossa proposta foi estudar a expressão imuno-histoquímica do p53
e PCNA em leucoplasias sem displasias, buscando correlacionar os resultados apenas com o grau de queratinização epitelial.
Para isso foram utilizadas as leucoplasias Grau I, II e III de Grinspan, num total de 24 lesões, todas localizadas em mucosa jugal.
A maior parte das leucoplasias, em seus diferentes graus de queratinização, apresentou expressão de p53 e PCNA. A marcação
do p53 restringiu-se às camadas basal e parabasal, enquanto a do PCNA ocorreu em praticamente todas as camadas epiteliais.
O padrão de expressão desses marcadores foi histologicamente e estatisticamente semelhante entre as lesões com esta
variação de queratinização. Ficou evidente que os epitélios não displásicos das leucoplasias possuem sinais sub-microscópicos
de alterações direcionadas à transformação maligna e o grau de queratinização não se correlacionou ao maior risco desse
acontecimento.
Unitermos: Leucoplasia; Imuno-histoquímica; p53; Antígeno nuclear de proliferação celular (PCNA).
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INTRODUCTION
Oral leukoplakias are admittedly premalignant lesions.
Many authors relate dysplastic alterations to a higher
tendency of these lesions for malignant transformations.
However, due to the subjectivity of dysplasia analysis and
to the possibility of non-dysplastic leukoplakias to develop
malignancy, there has been a need to develop other criteria,
more specifically to predict the malignant potential of these
lesions, such as immunohistochemistry (Bánóczy3, 1977;
Pindborg, et al.18, 1985; Burkhardt7, 1985; Karabulut, et al.14,
1995; Axéll, et al.2, 1996; Van Der Waal28, 1997; Wright30,
1998; Schepman, et al.23, 1998; Warnakulasuriya29, 2000).
Mutations in the p53 tumor suppressor gene are among
the most frequent genetic alterations associated to human
cancer and they result in a more stable genetic product,
which is detected by immunohistochemistry. Therefore, it
could be used as an indirect indicator of these alterations.
The gradual growing expression of the p53 protein, following
the tissue progression from normal epithelium to hyperplasia,
to dysplasia and to carcinoma, supports the concept of the
multistep process of tumorigenesis in the head and neck
region. It can suggest that p53 alterations might be a useful
biomarker in assessing risk of cancer development in normal
tissue and premalignant lesions exposed to carcinogenic
agents (Bennett, et al.4, 1991; Shin, et al.25, 1994; Greenblatt,
et al.11, 1994; Saranath, et al.21, 1999; Saito, et al.20, 1999).
Proliferating cell nuclear antigen (PCNA) is an acidic
intranuclear 36-kd polypeptide linked to cell cycle. Its
distribution in the cell cycle increases during the G1-phase,
peaks at the G1/S-phase interface, and decreases through
the G2-phase, reaching low levels which are virtually
undetectable by immunohistochemical methods in the M-
phase and quiescent cells. As PCNA is detected in its peak
distribution, it can be a useful marker for proliferating cells
(Celis and Celis9, 1985; Kurki, et al.16, 1988; Tsai and Jin26,
1995).
PCNA expression pattern can also be helpful in the
comprehension of the process of tumorigenesis, since there
is a gradual increase in terms of the number of PCNA-positive
cells with the progress from normal epithelium to malignancy.
Furthermore, the distribution of PCNA-positive cells in the
basal and parabasal layers in the normal epithelium and
benign lesions, and the distribution of PCNA-positive cells
in the suprabasal layers in dysplasias, carcinomas in situ,
and invasive carcinomas demonstrate that early dysplastic
alterations may occur without the histopathological signs
seen by optical microscopy through conventional
histochemical methods (Shin, et al.24, 1993; Shin, et al.25,
1994; Huang, et al.13, 1994; Tsuji, et al.27, 1995; Martinez-
Lara, et al.17, 1996).
Inasmuch as oral leukoplakias with innocent aspect can
also undergo malignant transformation independently of
their localization, the goal of this work was to assess the
epithelial proliferative activity of non-dysplastic leukoplakias
outside the areas of higher risk of malignant transformation
through PCNA and p53 immunohistochemistry detection,
and correlate the results with the amount of keratin produced
by the lesion. The quantification of keratin followed the
clinical and pathological criteria of Grinspan12 (1973) where
Degree I represents leukoplakia spots with discrete
hyperkeratosis, Degree II represents white plates showing
hyperkeratosis, and Degree III represents white plates and
verrucosis, with hyperkeratosis and papillomatosis.
MATERIAL AND METHODS
The materials consisted of 24 leukoplakias retrieved from
the files of the Histopathology Service of the Pathology
and Clinical Propedeutics Department of Araçatuba Dental
School, Brazil. These leukoplakias were graded and separated
in three groups following Grinspan’s criteria12 (1973): 8 degree
I leukoplakias, 8 degree II leukoplakias, and 8 degree III
leukoplakias.
Tissue sections of 4 µm were used for
immunohistochemical staining. The sections were dewaxed
in xylene and rehydrated in graded ethanol according to
standard procedures. Antigen retrieval was obtained by
treating the sections with citric acid (10 mM, 6.0 pH), three
times for 4 min, at 900 W in microwave oven. The
endogenous peroxidase was blocked with methanol and
hydrogen peroxide H2O2 (1:1, v/v) for 10 min.
The sections were incubated with primary antibodies
according to the data in Table 1. Then they were incubated
with secondary antibody for 30 min at room temperature
and finally incubated with Streptavidin-Biotin Complex for
30 min at room temperature. The 0.03 % diaminobenzidine
solution containing 0.6 mL of hydrogen peroxide was used
to visualize the peroxidase activity. After that, the slides
were lightly counterstained with Mayer’s hematoxylin.
The positive control was squamous cell carcinoma with
a known pattern. The negative control consisted of the
replacement of the primary antibody for 1 % bovine serum
albumin, diluted in phosphate saline solution (TRIS, pH 7.4).
Sections of 6 µm were stained with methanamine silver to
Antibodies Clone Dilution Incubation Time
PCNA* PC-10 1:600 Overnight
p53* DO-7 1:75 Overnight
TABLE 1- Monoclonal antibodies used
* Dako Corporation, Carpinteria
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verify the presence of Candida.
To assess the amount and distribution of PCNA and p53
expression on the immunostained slides, the expression of
the biomarker on digitized images was quantified using Leica
Qwin Image System (Image Processing and Analysis Sistem),
attached to a Leica microscope. The quantitative evaluation
involved visual identification of stained nuclei, and manual
circling of each nucleus with a light pen under high-power
microscopy (objective lens x 400), on a randomly selected




The p53 expression was observed in all groups. In degree
I, few p53-positive cells were observed in the basal and
parabasal cell layers in 5 sections (Figure 1), and 3 sections
were p53-negative. Six of the 8 sections of degree II showed
p53-positive cells in the basal and parabasal layers, while 2
sections showed p53-positive cells only in the basal layer.
In degree III, 2 sections showed few p53-positive cells in
the basal and parabasal layers, 4 sections showed few p53-
positive cells in the basal layer, and 2 sections did not show
p53-positive cells. Subjectively, p53 expression was higher
in degrees I and II. The score of p53-positive cells is in
Table 2.
PCNA
PCNA-positive cells were observed in the basal and
parabasal layers in all 8 sections in degree I, and 7 of those
sections also presented many positive cells in the suprabasal
layers. The degree II sections presented the same expression
as degree I sections, with PCNA-positive cells in the basal,
parabasal and suprabasal layers. In degree III, 7 sections
showed PCNA-positive cells in the basal and parabasal
layers (Figure 2) and 1 section showed PCNA-positive cells
in the suprabasal layer, too. Subjectively, PCNA expression
was higher in degrees I and II. PCNA-positive cells score is
in Table 3.
Statistical analysis was performed using one-way
analysis of variance for the number of stained cells. Statistical
difference was not observed concerning the number of p53-
positive (P=12.713 %) among the three degrees. For PCNA,
there was no statistically significant difference either
(P=5.599 %). However, because of the large difference shown
between the average of stained cells in degrees I and III
(130, 37), the Tukey Test was performed and revealed the
critical value of 139.89 at the 5% level. The result allowed us
to infer that there was a tendency for degree I to show a
higher number of stained cells than degree III, if the number
of sections were greater.
DISCUSSION
It has been considered that leukoplakias can show higher
or lower risk of malignant transformation depending on their
localization in oral mucosa, being the most dangerous the
ones located on floor of the mouth and tongue. Many authors
quote the oral mucosa as an area of higher incidence of
leukoplakias; however, this area presents low risk of
malignant transformation (Áxell1, 1984; Bouquot and Gorlin6,
1986). Thus, the lesions located in oral mucosa were studied,
avoiding epithelial dysplasias or microscopic malignant
alterations.
Although Candida was connected to the etiology of
leukoplakias (Bánóczy3, 1977); we decided not to include
leukoplakias with Candida in this work to avoid the
incidental influence of the fungus in the p53 and PCNA
immunohistochemical expression. Nevertheless, the fungus
was seen in all 8 sections of leukoplakias of degree III. Those
lesions could not be discarded because of the limited number
of samples. This finding raised the distrust that the fungus
was responsible for some of the alterations found in the
epithelium such as papillomatosis, in accordance with Kollar
et al.15 (1954), or verrucoid leukoplakias (Degree III) favor
opportunist infections by Candida. Lesions degrees I and
II did not present fungus in the histochemical analysis.
The subjectivity in the analysis of dysplastic alterations
in leukoplakias makes this criterion fallible to predict the
malignant potential of these lesions. Furthermore, the
Sections Degree I Degree II Degree III
1 13 8 0
2 9 38 0
3 8 6 16
4 18 53 17
5 10 8 8
6 0 49 22
7 0 14 9
8 0 1 4
TABLE 2- p53-positive cells score (Area: 19,500 µm.
Original magnification x 400)
FIGURE 1- Leukoplakia degree I. p53-positive cells in basal
and parabasal layers (original magnification: X400)
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presence of dysplasia does not always indicate malignant
transformation, and its absence does not prevent the
malignant transformation from occurring. All this, added to
the fact that leukoplakias without dysplastic alterations may
develop malignant transformation with time, makes it
necessary to use a new criterion to predict alterations of
this kind (Karabulut, et al.14, 1995; Áxell, et al.2, 1996; Van
Der Wall, et al.28, 1997; Schepman, et al.23, 1998; Cruz, et al.10,
1998; Warnakulasuriya29, 2000).
We looked for a biomarker of the potential of malignancy
of leukoplakias using p53 and PCNA through
immunohistochemistry, with attention to hyperkeratosis.
These biomarkers can show signs of malignant alterations
that are not microscopically visible with the conventional
histochemical methods in the epithelium of morphologically
normal leukoplakias.
According to the present results, there was no
statistically significant difference between the p53
expression in the three groups. It makes us believe that the
difference in degree of keratinization cannot be considered
as a significant datum to predict the malignant potential of
these lesions, at least in the study on this protein. However,
comparing them with the normal epithelium, which,
according to the literature, practically does not express this
protein, the frequency of detection was higher.
Alterations in gene p53 seem to be initial events in the
oral carcinogenesis, occurring before coarse phenotypic
alterations (Regezi, et al.19, 1995; Cruz, et al.10, 1998). This
could justify the p53 protein parabasal expression seen in
the sections of non-dysplastic leukoplakias. Moreover, it
corroborates our suspicions that signs of malignant
alterations that are not microscopically visible with the
conventional histochemical methods in the morphologically
normal epithelium of leukoplakias can occur before the
morphological alterations are detected. The gradual rise of
p53 protein expression following the tissue progress from
normal epithelium to hyperplasia, to dysplasia, and to
carcinoma is known (Shin, et al.25, 1994; Sauter, et al.22, 1994).
Inasmuch as a higher number of stained cells was found in
leukoplakias than the literature describes in the normal oral
epithelium, this could be an indication of the sequential
process of tumorigenesis (Saito, et al.20, 1999).
Despite the variation in the PCNA expression, the
difference between the 3 groups was not statistically
significant. The degree of keratinization of the leukoplakias
could not be related to higher or lower cell proliferative
activity. However, we suspect that the degree III lesions,
with papillomatosis, are more innocent than the degree I
and II lesions. Hence, the suspicion that verrucous lesions
with acanthosis had higher chances of developing malignant
transformation (Castro8, 2000) was not verified with these
biomarkers.
Martinez-Lara, et al.17 (1996) suggested that PCNA
suprabasal expression could work as a marker in initial
dysplasias, without histological signs. This can justify the
PCNA expression in suprabasal keratinocytes seen in the
sections and corroborate our doubt that there are signs of
malignant alterations in the morphologically normal
epithelium of leukoplakias that are not microscopically visible
with the conventional histochemical methods, and they occur
before the morphological alterations are detected.
Furthermore, this pattern of PCNA expression could
demonstrate evidence of malignancy or relation with DNA
repair (Huang, et al.13, 1994; Birchall, et al.5, 1997).
CONCLUSIONS
Thus, it may be conclude that the leukoplakias without
epithelial dysplasia present a different epithelium, in a
worrying morbid state, with biochemical but without
morphological alterations. This factor is already sufficient
to reinforce the real clinical meaning of leukoplakia, which
should not be interpreted as a simple hyperkeratotic alteration
of the oral mucosa, but might be seen as a potentially
dangerous lesion. By the way, the results confirm what the
clinical experience had already shown about the caution of
the clinician with this kind of lesions. However, it is still
impossible to obtain more accurate information about the
higher or lower risk of malignant transformation using these
biomarkers. Apparently, the amount of keratin does not
influence the risk of malignant transformation of non-
dysplastic leukoplakias of oral mucosa.
Sections   Degree I Degree II Degree III
1 366 201 34
2 193 387 145
3 344 256 374
4 104 267 66
5 365 290 237
6 345 340 146
7 559 279 164
8 218 280 285
TABLE 3- PCNA-positive cells score (Area: 19,500µm.
Original magnification x 400)
FIGURE 2- Leukoplakia degree III. PCNA-positive cells in
basal and parabasal layers (original magnification: X100).
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